90 related articles for article (PubMed ID: 17408401)
1. GATA1 mutational analysis in chronic myeloid leukaemia.
Halsey C; Fisher C; Strathdee G; Gibson B; Holyoake T; Vyas P; Graham G
Br J Haematol; 2007 May; 137(4):375-6. PubMed ID: 17408401
[No Abstract] [Full Text] [Related]
2. Mutations of the myeloid transcription factor CEBPA are not associated with the blast crisis of chronic myeloid leukaemia.
Pabst T; Stillner E; Neuberg D; Nimer S; Willman CL; List AF; Melo JV; Tenen DG; Mueller BU
Br J Haematol; 2006 May; 133(4):400-2. PubMed ID: 16643447
[TBL] [Abstract][Full Text] [Related]
3. Single-cell gene expression analysis reveals clonal architecture of blast-phase chronic myeloid leukaemia.
Nukina A; Kagoya Y; Watanabe-Okochi N; Arai S; Ueda K; Yoshimi A; Nannya Y; Kurokawa M
Br J Haematol; 2014 May; 165(3):414-6. PubMed ID: 24401018
[No Abstract] [Full Text] [Related]
4. NPM1 mutations occur rarely or not at all in chronic myeloid leukaemia patients in chronic phase or blast crisis.
Watkins DB; Hughes TP; White DL; D'Andrea RJ
Leukemia; 2013 Feb; 27(2):489-90. PubMed ID: 22791379
[No Abstract] [Full Text] [Related]
5. Simultaneous presence of major secondary chromosomal abnormalities in blast crisis of chronic myeloid leukemia.
Lu CM; Wang E; Lawrence HJ
Cancer Genet Cytogenet; 2007 Jan; 172(2):174-5. PubMed ID: 17213030
[No Abstract] [Full Text] [Related]
6. GATA-2 L359 V mutation is exclusively associated with CML progression but not other hematological malignancies and GATA-2 P250A is a novel single nucleotide polymorphism.
Zhang SJ; Shi JY; Li JY
Leuk Res; 2009 Aug; 33(8):1141-3. PubMed ID: 19304323
[TBL] [Abstract][Full Text] [Related]
7. [Progress on the study of related genes in patients with blast crisis of chronic myelocytic leukemia].
Xiong H; Chen X
Zhonghua Xue Ye Xue Za Zhi; 1999 Jan; 20(1):49-51. PubMed ID: 11498844
[No Abstract] [Full Text] [Related]
8. Mutations of the BCL10 gene are not associated with the blast crisis of chronic myeloid leukaemia.
Bose S; Goldman JM; Melo JV
Leukemia; 1999 Nov; 13(11):1894-6. PubMed ID: 10557068
[No Abstract] [Full Text] [Related]
9. [Kinetics of proliferation, differentiation and transcription of genes regulating apoptosis in cultured human BCR/ABL+ Ph+-cells].
Akhlynina TV; Gerasimova LP; Sarkisian GP; Borovkova TV; Dukhovenskaia EA; Manakova TE; Naĭdenova NM; Timofeev AM; Grineva NI
Tsitologiia; 2007; 49(10):889-900. PubMed ID: 18074781
[TBL] [Abstract][Full Text] [Related]
10. Additional t(1;11)(q21;q23) with mixed lineage leukemia rearrangement in T-blastic crisis of a Ph-positive chronic myeloid leukemia.
Otero L; Moellmann AC; Pombo-de-Oliveira MS; Ornellas MH; Pires V; Bouzas LF; Fernandez Tde S
Eur J Haematol; 2007 Aug; 79(2):179-81. PubMed ID: 17608714
[No Abstract] [Full Text] [Related]
11. Somatic mutations of PHF6 in patients with chronic myeloid leukemia in blast crisis.
Li X; Yao H; Chen Z; Wang Q; Zhao Y; Chen S
Leuk Lymphoma; 2013 Mar; 54(3):671-2. PubMed ID: 22928734
[No Abstract] [Full Text] [Related]
12. Variant (3;21) translocation and megakaryocytic involvement in blastic crisis of Philadelphia positive chronic myeloid leukaemia.
Aventin A; Mecucci C; Van Orshoven A; Delannoy A; Van den Berghe H
Br J Haematol; 1989 Apr; 71(4):562-4. PubMed ID: 2713276
[No Abstract] [Full Text] [Related]
13. CEBPA mutation in a case of chronic myeloid leukemia presenting in myeloid blast crisis.
Yin Y; Li J; Yan W; Cheng Z; Sun N; Zhang G
Leuk Lymphoma; 2017 Mar; 58(3):708-710. PubMed ID: 27379703
[No Abstract] [Full Text] [Related]
14. Amplification of BCR-ABL and t(3;21) in a patient with blast crisis of chronic myelogenous leukemia.
Phan CL; Megat Baharuddin PJ; Chin LP; Zakaria Z; Yegappan S; Sathar J; Tan SM; Purushothaman V; Chang KM
Cancer Genet Cytogenet; 2008 Jan; 180(1):60-4. PubMed ID: 18068536
[TBL] [Abstract][Full Text] [Related]
15. Deletion of chromosome 13: a rare form of cytogenetic evolution in blast phase of chronic myelogenous leukemia. Is there an association with favorable outcome?
Callera F; Rosa ES; Mulin CC
Leuk Res; 2007 May; 31(5):723-5. PubMed ID: 16919728
[No Abstract] [Full Text] [Related]
16. Extramedullary blast crisis in chronic myeloid leukemia--a case report.
Tondon R; Singh PA; Misra V; Singh M; Mohan S
Indian J Pathol Microbiol; 2005 Apr; 48(2):253-4. PubMed ID: 16758687
[TBL] [Abstract][Full Text] [Related]
17. Repetitive DNA hypomethylation in the advanced phase of chronic myeloid leukemia.
Roman-Gomez J; Jimenez-Velasco A; Agirre X; Castillejo JA; Navarro G; San Jose-Eneriz E; Garate L; Cordeu L; Cervantes F; Prosper F; Heiniger A; Torres A
Leuk Res; 2008 Mar; 32(3):487-90. PubMed ID: 17765966
[TBL] [Abstract][Full Text] [Related]
18. Cytoplasmic mutated nucleophosmin (NPM1) in blast crisis of chronic myeloid leukaemia.
Piccaluga PP; Sabattini E; Bacci F; Agostinelli C; Righi S; Salmi F; Testoni N; Paolini S; Castagnetti F; Martinelli G; Falini B; Pileri SA
Leukemia; 2009 Jul; 23(7):1370-1. PubMed ID: 19421226
[No Abstract] [Full Text] [Related]
19. Percentage of CD34 cells in a minimum 500-cell count in bone marrow trephines of patients with chronic myeloid leukaemia provides the best correlation with aspirate blast count.
Elliot V; Marin D; Horncastle D; Elderfield K; Apperley JF; Lampert IA; Naresh K
Br J Haematol; 2005 Aug; 130(3):460-1. PubMed ID: 16042700
[No Abstract] [Full Text] [Related]
20. GATA1 mutations in acute leukemia in children with Down syndrome.
Magalhães IQ; Splendore A; Emerenciano M; Figueiredo A; Ferrari I; Pombo-de-Oliveira MS
Cancer Genet Cytogenet; 2006 Apr; 166(2):112-6. PubMed ID: 16631466
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
